Riskpilot← Back to searchSign inGet full accessZPD A/S
A/SActiveCVR 32834825H E Bluhmes Vej 63Manufacture of basic pharmaceutical products · NACE 2110Est. 201050 employees
Revenue 2025
DKK 52,7M
+7% vs 2024
EBITDA margin
28.3%
-11% vs 2024
Equity ratio
92.2%
Financial strength
Net profit 2025
DKK 10,2M
-21% vs 2024
| Revenue | DKK 52,7M | +7% |
| EBITDA | DKK 14,9M | -11% |
| Net profit | DKK 10,2M | -21% |
| Total assets | DKK 236,1M | +7% |
| Equity | DKK 217,6M | +4% |
| Employees | 50 | — |
Legal name
ZPD A/S
CVR number
32834825
Legal form
Aktieselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
4. marts 2010
Share capital
DKK 1.000.000
Employees
50 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive fabrikation og handel med kemiske produkter.
Address
H E Bluhmes Vej 63
Phone
+4576106868
Email
info@zpd.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.395 | 45.173 | 47.779 | 39.769 | 40.790 | 41.504 | 36.750 | 35.568 | 35.200 | 37.256 | 43.788 | 49.315 | 52.704 |
| Staff expenses | -17.268 | -17.386 | -17.725 | -21.259 | -22.192 | -23.776 | -23.677 | -23.707 | -22.201 | -24.277 | -27.554 | -32.406 | -37.675 |
| EBITDA | 26.127 | 27.787 | 30.054 | 18.510 | 18.598 | 17.647 | 13.050 | 11.821 | 12.999 | 12.979 | 16.234 | 16.875 | 14.936 |
| Depreciation & amort. | -4.922 | -5.153 | -4.449 | -4.246 | -3.910 | -3.184 | -2.837 | -3.149 | -3.180 | -3.338 | -3.309 | -3.615 | -4.279 |
| EBIT | 21.205 | 22.634 | 25.605 | 14.264 | 14.688 | 14.463 | 10.213 | 8.672 | 9.819 | 9.641 | 12.925 | 13.260 | 10.657 |
| Net financials | -175 | 47 | 265 | -260 | -355 | 178 | -324 | -1.078 | -980 | -665 | 2.185 | 3.174 | 2.278 |
| Profit before tax | 21.030 | 22.681 | 25.870 | 14.004 | 14.333 | 14.641 | 9.889 | 7.594 | 8.839 | 8.976 | 15.110 | 16.434 | 12.935 |
| Tax | 4.872 | 5.706 | 6.054 | 3.075 | 3.155 | 3.202 | 2.184 | 1.640 | 1.876 | 1.909 | 3.286 | 3.570 | 2.715 |
| Net profit | 16.158 | 16.975 | 19.816 | 10.929 | 11.178 | 11.439 | 7.705 | 5.954 | 6.963 | 7.067 | 11.824 | 12.864 | 10.220 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 118.144 | 118.631 | 133.617 | 145.328 | 156.334 | 169.876 | 175.018 | 182.960 | 189.620 | 197.014 | 209.257 | 221.038 | 236.052 |
| Equity | 105.205 | 110.181 | 123.997 | 134.926 | 146.104 | 157.544 | 165.249 | 171.203 | 178.166 | 185.232 | 197.056 | 208.920 | 217.641 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 485 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 10.088 | 6.908 | 7.827 | 8.815 | 8.769 | 10.435 | 6.871 | 8.647 | 8.310 | 8.263 | 7.448 | 7.439 | 12.049 |
| Total debt | 10.088 | 6.908 | 7.827 | 8.815 | 8.769 | 10.435 | 7.356 | 8.647 | 8.310 | 8.263 | 7.448 | 7.439 | 12.049 |
EBITDA margin
28.3%
This company
15.8%
Market median
+79% vs market
20132025
Equity ratio
92.2%
This company
38.2%
Market median
+141% vs market
20132025
Return on equity
4.7%
This company
18.4%
Market median
-74% vs market
20132025
Net profit margin
19.4%
This company
8.1%
Market median
+140% vs market
20132025
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20132025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FM Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
RN Management | Management | 2016 | — | — |
HS Management | Management | 2022 | — | — |
HN Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
HR Management | Management | 2010 | — | — |
RV Management | Management | 2010 | — | — |
ER Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
PR Management | Management | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ZPD A/S 
JoinHealth ApSBoard members of ZPD A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frank Marek | Chief Executive Officer | 0 companies |
| Ryu Nakao | Management | 0 companies |
| Hiroyuki Shinya | Management | 0 companies |
| Hiroyasu Nishioka | Chief Executive Officer | 0 companies |
| Helle Rørvig | Management | 0 companies |
| Robert Villum Nielsen | Management | 0 companies |
| Elio Ramon Loo | Chief Executive Officer | 0 companies |
| Peter Rørvig | Management | 0 companies |
| Katsuyuki Ishii | Board of Directors | 0 companies |
| Kenichi Suzuki | Chairman | 0 companies |
| Hiroki Kato | Chairman | 0 companies |
| Mitsuru Iwai | Board of Directors | 0 companies |
| Masakazu Sakurai | Chairman | 0 companies |
| Makoto Kishimoto | Chairman | 0 companies |
| Svend Blankholm | Board of Directors | 0 companies |
| Akihisa Ono | Board of Directors | 0 companies |
| Keiji Ishiyama | Board of Directors | 0 companies |
| Nobuhito Hashimoto | Board of Directors | 0 companies |
| Shigeya Furuhata | Chairman | 0 companies |
| Mitsuhiro Tago | Board of Directors | 0 companies |
| Junkichi Izumi | Board of Directors | 0 companies |
| Ken Motegi | Board of Directors | 0 companies |
| Niels Ulrik Heine | Board of Directors | 0 companies |
| Yoshihiro Hiraga | Chairman | 0 companies |